Sign in
4/A

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001209191-15-047122

Options or other derivatives

  • Director acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wahlstrom Mats · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2015-04-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 20,000 D
2015-04-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X03/doc4a.xml…